@article{7b8ea2842ade4013a57e16607e5357e2,
title = "LIVER TRANSPLANTATION FOR TYPE I GLYCOGEN STORAGE DISEASE",
abstract = "A 161/2-year-old girl with type I glycogen storage disease was treated by orthotopic liver transplantation under cyclosporin/steroid immunosuppression. All metabolic stigmata of the disease were relieved and 1 year postoperatively she follows a normal diet and lifestyle.",
author = "{Jeffrey Malatack}, J. and Shunzaburo Iwatsuki and {Carlton Gartner}, J. and Thomas Roe and Finegold, {David N.} and Shaw, {Byers W.} and Zitelli, {Basil J.} and Starzl, {Thomas E.}",
note = "Funding Information: enteral alimentation that this has become the treatment of choice. The overnight feedings have usually been by gastric tube. Liver transplantation is a more specific option, but one which has been too dangerous to consider except for life- threatening complications such as those in our patient. However, the criteria for candidacy for this procedure will probably become less restrictive in view of the improved results with liver replacement that are being reported.8 Although liver transplantation does not provide glucose-6- phosphatase directly for the kidneys or intestine, there has been no evidence of incompleteness of metabolic correction by the normally functioning transplanted liver. This work was supported by research grants from the Veterans Administration; by project grant AM 29961 from the National Institutes of Health; and by grant RR 00084 from the General Clinical Research Centers Program of the Division of Research Resources, National Institutes of Health. Correspondence should be addressed to J. J. M. Addendum",
year = "1983",
month = may,
day = "14",
doi = "10.1016/S0140-6736(83)91910-4",
language = "English (US)",
volume = "321",
pages = "1073--1075",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8333",
}